A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
Mayo Clinic
Mayo Clinic
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Arvinas Inc.
SciTech Development, Inc.
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Washington University School of Medicine
Wake Forest University Health Sciences
Stanford University
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
University of Nebraska
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Barbara Ann Karmanos Cancer Institute
Jonsson Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
University of Wisconsin, Madison
University of Wisconsin, Madison
Mayo Clinic
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Takeda
Swiss Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
Virginia Commonwealth University
National Cancer Institute (NCI)
University of California, San Francisco
National Cancer Institute (NCI)
Massachusetts General Hospital
Progen Pharmaceuticals
Morphotek
Rutgers, The State University of New Jersey
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)
City of Hope Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
SWOG Cancer Research Network
SWOG Cancer Research Network
National Cancer Institute (NCI)
Indiana University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)